Clinical supply teams are increasingly interested in digital twins as trials become more global and operationally complex. But the technology itself shouldn’t be the starting point. A more useful question is: “Which recurring supply decision would improve if teams could test scenarios before committing?” 

A digital twin is a virtual representation of the clinical supply chain built on strong foundational data sources. It can help organizations monitor supply conditions and test scenarios before making decisions. In practice, that can improve visibility while helping teams align supply more closely with demand. When supported by trusted data and well-defined decision processes, a digital twin can move clinical supply planning toward a more predictive model. 

Even modest forecasting improvements can reduce carrying costs and expiry losses. They can also help protect continuity of supply for patients. 

A Reality Check: Why Digital Twin Success is Harder than it Appears 

The Gap Between the Long-Term Vision and Current Reality

Popular discussions frame digital twins as a real-time, one-to-one mirror of the clinical supply chain, providing seamless synchronization and immediate decision support. While that remains the long-term vision, it’s not yet the reality for most clinical supply environments. 

Many organizations still operate across disconnected systems. IRT and CTMS platforms may sit alongside manufacturing systems, external logistics partners, and spreadsheets. Data may update at different intervals, while partner information can arrive late or incomplete. Under those conditions, a twin can quickly become less of a live mirror and more of a delayed approximation. 

For many companies, what is called a digital twin is more accurately a digital model or decision-support environment. That distinction matters. A model can still provide meaningful value without continuously mirroring the supply chain – so leaders simply need to understand which decisions the model can reliably support and where its limitations remain. 

False Precision: When Better Technology Produces Worse Decisions

The deeper constraint is data quality, as a digital twin is only as good as its inputs. There are many potential pitfalls, but three common data challenges stand out the most: 

1. Forecast volatility driven by uncertain enrollment: patient recruitment remains one of the most uncertain variables in clinical trials, as forecast changes can significantly impact supply requirements.  
2. Delayed inventory visibility that lags behind actual support positions: latency in available inventory information may occur due to varying reporting schedules or manual data reconciliation processes.  
3. Manual overrides that reflect local judgement over system logic: many supply planners routinely override system-generated recommendations based on operational experience. 

These issues limit model accuracy and can create false precision by giving decision-makers confidence in outputs that don’t reflect operational reality. Before organizations invest in more advanced simulation, they need reliable inputs and common definitions. They also need governance that makes clear where the model informs a decision and where human judgment is still required. 

A Pragmatic Path Forward: Moving Beyond the Hype 

The first step is to identify a recurring, consequential decision that teams currently make with incomplete information. Platform selection and broad system integration can come later. 

• How much inventory should be produced before enrollment uncertainty is resolved?  
• When should supply be repositioned across depots or countries?  
• What is the patient-service risk of a slower recruitment scenario?  
• When should a planner accept a system recommendation, and when should judgment override it?  
• Which assumptions would materially change the packaging, manufacturing, or distribution strategy? 

From there, organizations can build the smallest model capable of improving that decision and compare its recommendations with actual outcomes. Expansion should follow only when teams understand where the model is dependable and where better data are still needed. Human judgment should remain explicit wherever the model cannot account for operational context. 

Success should be measured by whether the model improves patient service and reduces avoidable waste. It should also give planners more confidence when supply conditions change. 

Final Thoughts 

Digital twins can support more predictive clinical supply planning, but their value depends on the operating foundation beneath them. Fragmented systems and inconsistent data can limit what even a sophisticated model can reliably do. 

Before asking whether your organization needs a digital twin, identify the decision that needs to improve. Then determine the minimum data and process discipline required to support that decision responsibly. A focused model that improves a real planning decision can create more value than a broad digital twin that reproduces existing inefficiencies. 

We help clinical supply organizations identify where scenario modeling can improve a specific decision and assess the foundation required to support it. From there, we help build a practical path toward a capability teams can trust and use. The starting point is a better decision.